Foray Bioscience
a US startup profiled by the MIT Technology Review for making "wood products without trees"; it has raised a $3 million seed round framed around protecting and restoring natural forests.
- Country
- United States
Coverage
| CN | EU | US | |
|---|---|---|---|
| wood-construction | ✓ | ✓ | ✓ |
Regulatorsreachepaademe
Technologies
| Name | Cluster | Risk | |
|---|---|---|---|
| Cultivated wood & plant scaffolds | wood-construction | High | → |
Compiled by BIOECON via the bioecon-brief pipeline.
Compliance
Bioecon is an information intermediary; it is not a regulator, a certification body, or a legal advisor. When working with public-sector customers (procurement under 44-FZ / 223-FZ), Bioecon acts solely as an independent analytical platform, with no remuneration from suppliers.